Weill Medical College Of Cornell University
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1865-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://weill.cornell.edu
Phase II Study of Cabazitaxel in Refractory Metastatic Gastric or Gastroesophageal Adenocarcinoma
Phase 2
Completed
- Conditions
- Gastroesophageal AdenocarcinomaGastric AdenocarcinomaDistal Esophageal Adenocarcinoma
- Interventions
- First Posted Date
- 2012-12-28
- Last Posted Date
- 2018-04-03
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 85
- Registration Number
- NCT01757171
- Locations
- 🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸Karmanos Cancer Institute, Detroit, Michigan, United States
🇺🇸UCSF Comprehensive Cancer Center, San Francisco, California, United States
Cesium-131 Seed Brachytherapy Plus Subtotal Resection for Lung Cancer Patients
Not Applicable
Withdrawn
- Conditions
- Lung Cancer
- Interventions
- Radiation: Cs-131 brachytherapy seeds
- First Posted Date
- 2012-12-28
- Last Posted Date
- 2017-01-27
- Lead Sponsor
- Weill Medical College of Cornell University
- Registration Number
- NCT01757158
- Locations
- 🇺🇸
Weill Cornell Medical College, New York, New York, United States
Administration of AdVEGF-All6A+ to Myocardium of Individuals With Diffuse CAD Via Minimally Invasive Surgery
Phase 1
Withdrawn
- Conditions
- Coronary Artery Disease
- Interventions
- Biological: AdVEGF-All6A+Biological: AdNull
- First Posted Date
- 2012-12-28
- Last Posted Date
- 2021-01-27
- Lead Sponsor
- Weill Medical College of Cornell University
- Registration Number
- NCT01757223
Phase II Study of Tocilizumab for Patients With Glucocorticoid-refractory Acute GVHD After Allogeneic Hematopoetic Stem Cell Transplant (HSCT)
Phase 2
Terminated
- Conditions
- Glucocorticosteroid Refractory Acute GVHD
- Interventions
- Drug: Toclizumab
- First Posted Date
- 2012-12-28
- Last Posted Date
- 2018-06-11
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 2
- Registration Number
- NCT01757197
- Locations
- 🇺🇸
Weill Cornell Medical College, New York, New York, United States
Photodynamic Therapy (PDT) for Palliation of Cholangiocarcinoma
Phase 2
- Conditions
- Biliary StrictureCholangiocarcinomaBiliary ObstructionBile Duct Cancer
- Interventions
- Procedure: Photodynamic Therapy
- First Posted Date
- 2012-12-21
- Last Posted Date
- 2017-02-20
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 55
- Registration Number
- NCT01755013
- Locations
- 🇺🇸
Weill Cornell Medical College, New York, New York, United States
Outcome Analysis for Minimally Invasive Spine Surgery and Navigation
Completed
- Conditions
- Degenerative Disc Disease
- First Posted Date
- 2012-12-18
- Last Posted Date
- 2024-03-29
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 200
- Registration Number
- NCT01751841
- Locations
- 🇺🇸
Weill Cornell Brain and Spine Center, New York, New York, United States
Randomized HaploCord Blood Transplantation vs. Double Umbilical Cord Blood Transplantation for Hematologic Malignancies
Phase 2
Terminated
- Conditions
- Acute Myelogenous LeukemiaMyelodysplastic SyndromeAcute Lymphocytic LeukemiaHodgkin's LymphomaNon-Hodgkin's Lymphoma
- Interventions
- Device: CliniMACS® CD34 Reagent SystemProcedure: Double Umbilical Cord Blood TransplantationProcedure: Haplo-Identical Cord Transplantation
- First Posted Date
- 2012-12-10
- Last Posted Date
- 2018-07-11
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 2
- Registration Number
- NCT01745913
- Locations
- 🇺🇸
Weill Cornell Medical College, New York, New York, United States
Doxycycline for COPD in HIV-Infected Patients
Not Applicable
Completed
- Conditions
- HIVChronic Obstructive Pulmonary Disease (COPD)Emphysema
- Interventions
- Drug: Placebo (sugar pill)
- First Posted Date
- 2012-12-06
- Last Posted Date
- 2022-07-21
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 61
- Registration Number
- NCT01744093
- Locations
- 🇺🇸
Genetic Medicine, New York, New York, United States
Dexamethasone for the Prevention of Post-operative Nausea and Vomiting in Patients Undergoing Cesarean Sections
Phase 4
Completed
- Conditions
- Postoperative Nausea and Vomiting
- Interventions
- Drug: Placebo
- First Posted Date
- 2012-11-27
- Last Posted Date
- 2019-10-15
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 122
- Registration Number
- NCT01734161
- Locations
- 🇺🇸
Weill Cornell Medical College, New York, New York, United States
Left Ventricular Volume and Ejection Fraction: Validation of Real Time 3 Dimensional Transesophageal Echocardiography
Withdrawn
- Conditions
- 3D Transesophageal and Transthoracic Echocardiogram
- Interventions
- Procedure: transesophageal echocardiography (TEE)Procedure: thermodilutionProcedure: transthoracic echocardiography (TTE)
- First Posted Date
- 2012-11-27
- Last Posted Date
- 2018-06-28
- Lead Sponsor
- Weill Medical College of Cornell University
- Registration Number
- NCT01734174
- Locations
- 🇺🇸
Weill Cornell Medical College, New York, New York, United States
© Copyright 2025. All Rights Reserved by MedPath